Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
Andre BredthauerManuel KopfmuellerMichael GruberSophie-Marie PfaehlerKarla LehleWalter PetermichlTimo SeyfriedDiane Inge BitzingerAndreas RedelPublished in: Cardiovascular therapeutics (2020)
Our data provide evidence that anticoagulants have an inhibitory effect on the extent of PMN migration and chemotactic migration efficiency, thus indicating their potential immune-modulatory and prothrombotic effects.